1. Home
  2. KMDA vs CLFD Comparison

KMDA vs CLFD Comparison

Compare KMDA & CLFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • CLFD
  • Stock Information
  • Founded
  • KMDA 1990
  • CLFD 1979
  • Country
  • KMDA Israel
  • CLFD United States
  • Employees
  • KMDA N/A
  • CLFD N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • CLFD Telecommunications Equipment
  • Sector
  • KMDA Health Care
  • CLFD Utilities
  • Exchange
  • KMDA Nasdaq
  • CLFD Nasdaq
  • Market Cap
  • KMDA 442.1M
  • CLFD 468.1M
  • IPO Year
  • KMDA N/A
  • CLFD N/A
  • Fundamental
  • Price
  • KMDA $7.46
  • CLFD $31.84
  • Analyst Decision
  • KMDA Strong Buy
  • CLFD Strong Buy
  • Analyst Count
  • KMDA 2
  • CLFD 3
  • Target Price
  • KMDA $14.50
  • CLFD $46.67
  • AVG Volume (30 Days)
  • KMDA 346.0K
  • CLFD 151.2K
  • Earning Date
  • KMDA 03-05-2025
  • CLFD 02-06-2025
  • Dividend Yield
  • KMDA N/A
  • CLFD N/A
  • EPS Growth
  • KMDA 124.29
  • CLFD N/A
  • EPS
  • KMDA 0.27
  • CLFD N/A
  • Revenue
  • KMDA $158,380,000.00
  • CLFD $167,951,000.00
  • Revenue This Year
  • KMDA $15.37
  • CLFD $9.66
  • Revenue Next Year
  • KMDA $8.58
  • CLFD $18.99
  • P/E Ratio
  • KMDA $28.13
  • CLFD N/A
  • Revenue Growth
  • KMDA 4.52
  • CLFD N/A
  • 52 Week Low
  • KMDA $4.74
  • CLFD $27.06
  • 52 Week High
  • KMDA $9.15
  • CLFD $44.83
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 52.89
  • CLFD 37.28
  • Support Level
  • KMDA $7.51
  • CLFD $32.34
  • Resistance Level
  • KMDA $8.35
  • CLFD $33.55
  • Average True Range (ATR)
  • KMDA 0.41
  • CLFD 1.42
  • MACD
  • KMDA -0.02
  • CLFD -0.49
  • Stochastic Oscillator
  • KMDA 33.20
  • CLFD 0.00

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About CLFD Clearfield Inc.

Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a range of products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has a global presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.

Share on Social Networks: